Idelalisib Active Not Recruiting Phase 1 Trials for chronic, recurrent Lymphoid Leukemia Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02787369ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL